Dunhill Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Dunhill Financial's BIIB Position: Q3 2026 in Review
Dunhill Financial increased its Biogen (BIIB) stake by 3,667% in Q3 2026, buying an estimated $46.7K and bringing the position to 226 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #965.
Dunhill Financial first reported a position in BIIB in Q4 2023 and has held it in 12 quarters since. The position peaked at $23.3K in Q4 2024. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Dunhill Financial held 226 shares of Biogen worth $1.66K as of Q3 2026.
- Dunhill Financial bought 220 Biogen shares in Q3 2026, an estimated $46.7K.
- Biogen made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #965 holding.
- Dunhill Financial first reported a position in Biogen in Q4 2023 and has held it in 12 quarters since.
- Dunhill Financial's Biogen position peaked at $23.3K in Q4 2024.
- 1,059 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.